Skip to main content
. 2017 Mar 16;26(1):182–192. doi: 10.1016/j.jfda.2017.02.002

Figure 5.

Figure 5

Effects of EERFB on the activities of caspase-3 and caspase-9 (A), and the suppression of cell death by caspase-3 and caspase-9 inhibitors (B) in HL-60 human leukemic cells. Cells were pretreated with 25 μM caspase-3 (Z-DEVD-FMK) and caspase-9 (Z-LEHD-FMK) inhibitors for 3 hours and then treated with 100 μg/mL EERFB for 24 hours. The results are the mean ± SD of three experiments performed in duplicate. *p < 0.05 is significantly different compared with the control. #p < 0.05 compared with EERFB alone. EERFB =ethanolic extract of the roots of Ficus beecheyana; SD =standard deviation; Z-DEVD-FMK =caspase-3/CPP32 inhibitor; Z-LEHD-FMK =caspase-9/Mch6 inhibitor.